P2RX7 and melanoma: Melanoma growth is accelerated in the P2X7 null host (Fig. 1a–c), in correlation with a significant decrease in the CD8+ and CD4+ effector T cells (Teff, CD4+, CD25−) infiltrate (Fig. 1d, e).